News

Thumbnail

Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

Heart Rhythm 2025 Heart Rhythm Society President Kenneth A. Ellenbogen, MD

Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.

Gregg Stone, MD, FACC, FSCAI, Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai Hospital in New York, presented the results of the long-awaited STEMI Door or Unloading time trial, which takes a different approach to first using a percutaneous heart pump to unload the heart 30 minutes prior to PCI interventions to try and prevent common complications and improve outcomes.

Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.

orforglipron Foundayo Eli Lilly

The FDA asked, and Eli Lilly and Company delivered. The company now hopes to secure an additional approval for orforglipron/Foundayo that covers the treatment of type 2 diabetes.

healthcare value value-based care money dollar

Cardiologists in the United States now earn an average annual income of $575,000. That represents an increase of 10% compared to the previous year.

Surgeons Operating On Patient

New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.

The new clinic wants to keep patients out of hospital EDs when possible and provide care at a lower cost.

Thumbnail

The family of a teenage girl who died unexpectedly in 2025 has sued two energy drink distributors.

The new clinic wants to keep patients out of hospital EDs when possible and provide care at a lower cost.

Thumbnail

The family of a teenage girl who died unexpectedly in 2025 has sued two energy drink distributors.

artificial intelligence consultation

AI can help care teams get additional value out of routine head CT images.

pediatric patient young patient child chlidren kid

Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.

Around the web

The ramifications of the conflict in the Middle East may soon extend beyond the gas pump and into the healthcare sector, experts are cautioning.